--- title: "Earnings To Watch: CVS Health (CVS) Reports Q3 Results Tomorrow" description: "CVS Health is set to report its Q3 results tomorrow before market hours. Last quarter, it exceeded revenue expectations by 5.1%, with revenues of $98.92 billion. Analysts predict a 3.5% year-on-year r" type: "news" locale: "en" url: "https://longbridge.com/en/news/262996581.md" published_at: "2025-10-28T03:10:08.000Z" --- # Earnings To Watch: CVS Health (CVS) Reports Q3 Results Tomorrow > CVS Health is set to report its Q3 results tomorrow before market hours. Last quarter, it exceeded revenue expectations by 5.1%, with revenues of $98.92 billion. Analysts predict a 3.5% year-on-year revenue growth to $98.76 billion this quarter, with adjusted earnings expected at $1.36 per share. CVS has missed revenue estimates twice in the past two years. The healthcare sector has seen positive sentiment, with CVS shares up 9.2% recently, and an average analyst price target of $86.20 compared to its current price of $82.50. Diversified healthcare company CVS Health will be reporting results this Wednesday before market hours. Here’s what investors should know. CVS Health beat analysts’ revenue expectations by 5.1% last quarter, reporting revenues of $98.92 billion, up 8.4% year on year. It was a stunning quarter for the company, with an impressive beat of analysts’ same-store sales estimates and a solid beat of analysts’ revenue estimates. Is CVS Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting CVS Health’s revenue to grow 3.5% year on year to $98.76 billion, slowing from the 6.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.36 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. CVS Health has missed Wall Street’s revenue estimates twice over the last two years. Looking at CVS Health’s peers in the healthcare providers & services segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Elevance Health delivered year-on-year revenue growth of 11%, meeting analysts’ expectations, and Molina Healthcare reported revenues up 11%, topping estimates by 4.7%. Elevance Health traded down 2.5% following the results while Molina Healthcare was also down 17.3%. Read our full analysis of Elevance Health’s results here and Molina Healthcare’s results here. There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 7% on average over the last month. CVS Health is up 9.2% during the same time and is heading into earnings with an average analyst price target of $86.20 (compared to the current share price of $82.50). P.S. While everyone's chasing Nvidia, we found a hidden AI semiconductor winner trading at a fraction of the price. See our #1 pick before Wall Street catches on. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. ### Related Stocks - [CVS.US - CVS Health](https://longbridge.com/en/quote/CVS.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | CVS Health steigert GAAP-Gewinn je Aktie im vierten Quartal (Q4) 2025 auf 2,30 USD mit einem Plus von 76,9 Prozent | CVS Health reported a significant increase in its Q4 2025 financial results, with net income attributable to shareholder | [Link](https://longbridge.com/en/news/275448589.md) | | Applied Finance Capital Management LLC Decreases Holdings in CVS Health Corporation $CVS | Applied Finance Capital Management LLC reduced its holdings in CVS Health Corporation by 15.4% in Q3, owning 184,244 sha | [Link](https://longbridge.com/en/news/275424889.md) | | CVS Health Shows Strength as Strategic Shifts Boost Its Health-Insurance and Pharmacy Arms | CVS Health is showing signs of improvement due to strategic shifts in its health-insurance and retail-pharmacy divisions | [Link](https://longbridge.com/en/news/275574465.md) | | Is CVS Health Stock (CVS) a Buy Ahead of Q4 Earnings? | Health insurer CVS Health (CVS) is set to report Q4 earnings this week. The stock is down nearly 4% in the year-to-date | [Link](https://longbridge.com/en/news/275445554.md) | | Cvs Health Exec Says Co Is Advocating For Higher Medicare Advantage Payments Issued By Cms | Cvs Health Exec Says Co Is Advocating For Higher Medicare Advantage Payments Issued By Cms | [Link](https://longbridge.com/en/news/275465529.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.